Skip to content
Use caution Medical device recall · FDA · Published May 29, 2026

Hamilton Medical Breathing Circuit Sets Risk: Exhalation Obstruction During Ventilation

Hamilton Medical recalls coaxial breathing circuit sets (REFs 260127-260168) used with C1/T1/MR1 ventilators. Membranes may stick to valves, causing exhalation obstruction and oxygen desaturation if not tested before use.

🇺🇸 FDA recall #Z-2463-2026Medical deviceHamilton Medical ›
Take action

Contact the company

Recalling firmHamilton Medical AGParc Industrial Vial 10 · Domat/Ems, Switzerland
✎ GovInfoNow plain-language explainer

Hamilton Medical is recalling coaxial breathing circuit sets used with specific ventilators because membranes inside the expiratory valves can stick to the valve body. This may cause exhalation obstruction alarms, leading to inadequate ventilation and oxygen desaturation if not properly tested before use. Read more at govinfonow.com/recall/49054-hamilton-medical-breathing-circuit-sets-risk-exhalation-obstruction-during-ventilation.

Source Summary by GovInfoNow · govinfonow.com/recall/49054-hamilton-medical-breathing-circuit-sets-risk-exhalation-obstruction-during-ventilation · Updated August 10, 2026 · FDA enforcement record: FDA #Z-2463-2026

Cite this page

“Hamilton Medical Breathing Circuit Sets Risk: Exhalation Obstruction During Ventilation.” GovInfoNow, updated August 10, 2026. https://govinfonow.com/recall/49054-hamilton-medical-breathing-circuit-sets-risk-exhalation-obstruction-during-ventilation. Based on FDA recall #Z-2463-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2463-2026%22&limit=1).

The FDA announced on May 29, 2026, that Hamilton Medical AG is voluntarily recalling Breathing circuit sets (REFs 260127, 260128, 260167, 260168) due to expiratory valve membrane adhesion risks. This defect may cause inadequate ventilation and oxygen desaturation.

How to tell if you have it

  • Brand: Hamilton Medical
  • Product: Breathing circuit set, coaxial
  • REFs: 260127, 260128, 260167, 260168
  • Lot numbers: 200379 through 205050
  • Used with: HAMILTON-C1, HAMILTON-T1, and HAMILTON-MR1 ventilators

The hazard

The ventilator coaxial breathing circuit may have expiratory valve sets with membranes sticking to the valve body. This issue is not detectable during pre-operative tests and may result in an "exhalation obstructed" alarm, leading to inadequate ventilation and oxygen desaturation.

Context

GovInfoNow's records show Hamilton Medical AG has issued 11 other recalls since March 9, 2018. Recent brand recalls include a May 22, 2026 IntelliCuff recall for leakage errors and June 26, 2025 breathing circuit recalls for crack risks. Other recent recalls of similar products include Medline Hudson RCI Breathing Circuits (July 13, 2026) and Medline Airway Exam Kit (Feb. 16, 2026).

How to tell if you have this one

Check for reference numbers 260127, 260128, 260167, or 260168 on the breathing circuit set. These sets are used with Hamilton C1, T1, or MR1 ventilators. Lot numbers between 200379 and 205050 (inclusive) are affected.

  • Brand
    Hamilton Medical
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Test Lung Action Before Use

    Perform a pre-use test to check for exhalation obstruction. If the alarm occurs, remove the expiratory valve set to overcome membrane adhesion.

Where it went and when

Where it was distributed

Distributed nationwide; the notice names 42 states.

Alaska: named in the noticeAKMaine: named in the noticeMEVermont: named in the noticeVTNew Hampshire: named in the noticeNHWashington: named in the noticeWAIdaho: named in the noticeIDMontana: nationwideMTNorth Dakota: named in the noticeNDMinnesota: named in the noticeMNIllinois: named in the noticeILWisconsin: named in the noticeWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: nationwideRIMassachusetts: nationwideMAOregon: named in the noticeORNevada: nationwideNVWyoming: named in the noticeWYSouth Dakota: named in the noticeSDIowa: named in the noticeIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: named in the noticeCTCalifornia: named in the noticeCAUtah: named in the noticeUTColorado: named in the noticeCONebraska: named in the noticeNEMissouri: named in the noticeMOKentucky: named in the noticeKYWest Virginia: named in the noticeWVVirginia: named in the noticeVAMaryland: nationwideMDDelaware: named in the noticeDEArizona: named in the noticeAZNew Mexico: named in the noticeNMKansas: named in the noticeKSArkansas: named in the noticeARTennessee: named in the noticeTNNorth Carolina: nationwideNCSouth Carolina: nationwideSCDistrict of Columbia: nationwideDCOklahoma: named in the noticeOKLouisiana: named in the noticeLAMississippi: nationwideMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: named in the noticeHITexas: named in the noticeTXFlorida: named in the noticeFLPuerto Rico: named in the noticePR

FDA distribution: “US Nationwide distribution including in the states of KS, WA, VT, TX, WI, AR, OH, PA, CA, CO, ID, AZ, ME, MO, MI, IL, OR, VA, FL, NJ, SD, NY, NM, TN, CT, NE, OK, AL, GA, KY, NH, WY, ND, IN, UT, WV, DE, IA, PR, MN, LA, AK, HI.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Michigan, Minnesota, Missouri, Nebraska, New Hampshire, New Jersey, New Mexico, New York, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming.

Recall timeline

FDA published this recall 40 days after the firm started it.

1. Firm started the recall: May 29, 202612. FDA classified it Class I: Jun 30, 202623. Published in FDA’s Enforcement Report: Jul 8, 202632026
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-2463-2026 (May 29, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2463-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 10, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA